Advisory Services Network, LLC Cellectis S.A. Transaction History

Advisory Services Network, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 05, 2021	SELL	$11.94 - $16.09 $1,194 - $1,609	-100 Closed	0 $0
Q2 2021 Aug 12, 2021	BUY	$14.36 - $20.93 $1,436 - $2,093	100 New	100 $2,000
Q1 2021 May 24, 2021	SELL	$18.19 - $33.25 $1,819 - $3,325	-100 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$15.7 - $20.84 $1,570 - $2,084	100 New	100 $2,000
Q4 2019 Feb 04, 2020	SELL	$9.73 - $19.31 $642 - $1,274	-66 Closed	0 $0
Q1 2019 May 20, 2019	SELL	$15.53 - $19.75 $7,050 - $8,966	-454 Reduced 87.31%	66 $1,000
Q4 2018 Feb 15, 2019	SELL	$15.58 - $28.41 $55,760 - $101,679	-3,579 Reduced 87.31%	520 $9,000
Q2 2018 Jul 27, 2018	BUY	$27.78 - $38.53 $583 - $809	21 Added 0.51%	4,099 $123,000
Q1 2018 Apr 23, 2018	BUY	$27.78 - $35.19 $113,286 - $143,504	4,078 New	4,078 $0

10.8M

5.9K

1.4K

Ticker CLLS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,510,800
Market Cap $71M
Description
Cellectis S.A., a clinical stage biotechnological company, develops immuno-oncology products based on gene-edited T-cells that express chimeric antigen receptors to target and eradicate cancer cells. It operates through two segments, Therapeutics and Plants. The company is developing UCART19, an allogeneic T-cell product candidate for the treatm...

Get notified when there are updates to the investment portfolio of Advisory Services Network, LLC, based on Form 13F filings with the SEC.

Stay updated on Advisory Services Network, LLC with notifications on news.